NFKB1 and diabetes mellitus: Because diabetes-induced NF-kB activation and subsequent inflammation contribute to retinal endothelial cell (RECs) death and diabetic retinopathy, we hypothesized that miR-146 is a therapeutic target for treatment of diabetic retinopathy [58,59].